Civica announces plans to manufacture generic drugs in commonwealth Shawna De La Rosa | Jan 21, 2021
Share this:
The pharmaceutical firm Civica will invest $124.5 million to establish its first in-house pharmaceutical manufacturing operation in the Petersburg, a venture that will create 186 jobs. The nonprofit generic drug company launched in 2018 to address the problem of chronic generic drug shortages and high prices.
It is a partner in the government-funded Phlow Corporation, Medicines for All Institute and AMPAC Fine Chemicals affiliation. Phlow executed a $354 million Medicines for All Institute contract with the U.S. Biomedical Advanced Research and Development Authority to produce essential medications using advanced manufacturing processes. Medicines for All Institute is based out of the College of Engineering at Virginia Commonwealth University.
PharmaceuticalmManufacturer Civica Inc. to Create 186 New Jobs in City of Petersburg
emporiaindependentmessenger.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from emporiaindependentmessenger.com Daily Mail and Mail on Sunday newspapers.
mRNA technology used in COVID-19 vaccines deemed safe, has been studied for decades, expert says
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.